Calescibetta, A., Dalton, R., Fortenbery, N., Ward, G., Christiansen, S., Chen, X., Cheng, P., Razabdouski, T., Glode, A. J., Tu, N., Trinh, T. L., Liu, J., Wright, K. L., Wei, S., Eksioglu, E. A. (2026). Correction: Combining lenalidomide with IL-2 family of cytokines enhances activating receptor and perforin/granzyme expression in NK cells. PLoS ONE. https://doi.org/10.1371/journal.pone.0348020